201 related articles for article (PubMed ID: 17158873)
1. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
Scola AM; Higginbottom A; Partridge LJ; Reid RC; Woodruff T; Taylor SM; Fairlie DP; Monk PN
J Biol Chem; 2007 Feb; 282(6):3664-71. PubMed ID: 17158873
[TBL] [Abstract][Full Text] [Related]
2. C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2.
Croker DE; Halai R; Fairlie DP; Cooper MA
Immunol Cell Biol; 2013; 91(10):625-33. PubMed ID: 24060963
[TBL] [Abstract][Full Text] [Related]
3. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
Cain SA; Monk PN
J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
[TBL] [Abstract][Full Text] [Related]
4. C5L2, a nonsignaling C5A binding protein.
Okinaga S; Slattery D; Humbles A; Zsengeller Z; Morteau O; Kinrade MB; Brodbeck RM; Krause JE; Choe HR; Gerard NP; Gerard C
Biochemistry; 2003 Aug; 42(31):9406-15. PubMed ID: 12899627
[TBL] [Abstract][Full Text] [Related]
5. Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines.
Johswich K; Martin M; Thalmann J; Rheinheimer C; Monk PN; Klos A
J Biol Chem; 2006 Dec; 281(51):39088-95. PubMed ID: 17068344
[TBL] [Abstract][Full Text] [Related]
6. The human complement fragment receptor, C5L2, is a recycling decoy receptor.
Scola AM; Johswich KO; Morgan BP; Klos A; Monk PN
Mol Immunol; 2009 Mar; 46(6):1149-62. PubMed ID: 19100624
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of C5a receptor agonists from phage display libraries.
Cain SA; Higginbottom A; Monk PN
Biochem Pharmacol; 2003 Nov; 66(9):1833-40. PubMed ID: 14563493
[TBL] [Abstract][Full Text] [Related]
8. Functions of C5a receptors.
Ward PA
J Mol Med (Berl); 2009 Apr; 87(4):375-8. PubMed ID: 19189071
[TBL] [Abstract][Full Text] [Related]
9. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein.
Kalant D; Cain SA; Maslowska M; Sniderman AD; Cianflone K; Monk PN
J Biol Chem; 2003 Mar; 278(13):11123-9. PubMed ID: 12540846
[TBL] [Abstract][Full Text] [Related]
10. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.
Bamberg CE; Mackay CR; Lee H; Zahra D; Jackson J; Lim YS; Whitfeld PL; Craig S; Corsini E; Lu B; Gerard C; Gerard NP
J Biol Chem; 2010 Mar; 285(10):7633-44. PubMed ID: 20044484
[TBL] [Abstract][Full Text] [Related]
11. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand.
Crass T; Bautsch W; Cain SA; Pease JE; Monk PN
Biochemistry; 1999 Jul; 38(30):9712-7. PubMed ID: 10423250
[TBL] [Abstract][Full Text] [Related]
12. C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology.
Poursharifi P; Lapointe M; Pétrin D; Devost D; Gauvreau D; Hébert TE; Cianflone K
Cell Signal; 2013 Apr; 25(4):910-8. PubMed ID: 23268185
[TBL] [Abstract][Full Text] [Related]
13. Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus.
Postma B; Kleibeuker W; Poppelier MJ; Boonstra M; Van Kessel KP; Van Strijp JA; de Haas CJ
J Biol Chem; 2005 Jan; 280(3):2020-7. PubMed ID: 15542591
[TBL] [Abstract][Full Text] [Related]
14. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
[TBL] [Abstract][Full Text] [Related]
15. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
[TBL] [Abstract][Full Text] [Related]
16. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
Monk PN; Barker MD; Partridge LJ; Pease JE
J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
[TBL] [Abstract][Full Text] [Related]
17. C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism.
Otto M; Hawlisch H; Monk PN; Müller M; Klos A; Karp CL; Köhl J
J Biol Chem; 2004 Jan; 279(1):142-51. PubMed ID: 14570896
[TBL] [Abstract][Full Text] [Related]
18. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
19. Complement C5a receptors C5L2 and C5aR in renal fibrosis.
Martin IV; Bohner A; Boor P; Shagdarsuren E; Raffetseder U; Lammert F; Floege J; Ostendorf T; Weber SN
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F35-F46. PubMed ID: 28903945
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a functional role of the second C5a receptor C5L2.
Gao H; Neff TA; Guo RF; Speyer CL; Sarma JV; Tomlins S; Man Y; Riedemann NC; Hoesel LM; Younkin E; Zetoune FS; Ward PA
FASEB J; 2005 Jun; 19(8):1003-5. PubMed ID: 15784721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
